{{Rsnum
|rsid=987106
|Gene=IL7R
|Chromosome=5
|position=35875491
|Orientation=minus
|GMAF=0.4601
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=IL7R
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 30.1 | 52.2 | 17.7
| HCB | 10.2 | 32.1 | 57.7
| JPT | 8.8 | 42.5 | 48.7
| YRI | 32.0 | 45.6 | 22.4
| ASW | 26.3 | 52.6 | 21.1
| CHB | 10.2 | 32.1 | 57.7
| CHD | 7.3 | 40.4 | 52.3
| GIH | 17.8 | 43.6 | 38.6
| LWK | 27.3 | 50.9 | 21.8
| MEX | 10.3 | 56.9 | 32.8
| MKK | 22.4 | 49.4 | 28.2
| TSI | 23.5 | 58.8 | 17.6
| HapMapRevision=28
}}{{Report GE
|PubMed=17660816
|Source=pubmed
|AffyProbeset=SNP_A-4264835
|AffyOrientation=same
|AlleleA=A
|AlleleB=T
|onGW5=1
|rsid=987106
|ancestral=T
|RiskPopulation=
|RiskAllele=T
|CaseFreq=
|ControlFreq=
|OddsRatioHet=0.79
|OddsRatioHom=1.26
|OddsRatioAll=
|Disease=Multiple sclerosis
|DiseaseSymbol=MS
}}

{{ neighbor
| rsid = 3194051
| distance = 681
}}

rs987106 increases susceptibility to Multiple sclerosis 0.79 times for heterozygotes (AT) and 1.26 times for homozygotes (TT) {{PMID|17660816}}

{{PharmGKB
|RSID=rs987106
|Name_s=
|Gene_s=IL7R
|Feature=
|Evidence=PubMed ID:17660816
|Annotation=In a nordic case-control group consisted of 1,820 individuals with multiple sclerosis and 2,634 healthy controls this SNP in intron 6 of the IL7R gene confirmed association with multiple sclerosis.
|Drugs=
|Drug Classes=
|Diseases=Multiple Sclerosis
|Curation Level=Curated
|PharmGKB Accession ID=PA162355787
}}

{{PharmGKB
|RSID=rs987106
|Name_s=
|Gene_s=IL7R
|Feature=
|Evidence=PubMed ID:17660816
|Annotation=In a case-control study of Nordic populations, rs987106 was associated with risk of multiple sclerosis.
|Drugs=
|Drug Classes=
|Diseases=Multiple Sclerosis
|Curation Level=Curated
|PharmGKB Accession ID=PA162356125
}}

{{PMID Auto
|PMID=22329520
|Title=Identification of IL7RA risk alleles for rapid progression during HIV-1 infection: a comprehensive study in the GRIV cohort
}}

{{PMID|18563381}} Study of the association between the CAPSL-IL7R locus and type 1 diabetes.

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs987106
|overall_frequency_n=5844
|overall_frequency_d=10758
|overall_frequency=0.543224
|n_genomes=37
|n_genomes_annotated=0
|n_haplomes=51
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Affy500k}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}